Skip to main content
. 2015 Jan 22;22(2):285–292. doi: 10.1016/j.chembiol.2014.10.023

Figure 3.

Figure 3

Comparison of Implant P24 Levels, T lymphocytes, and HIV-1 RNA in the SCID-hu Thy/Liv Mouse Model, Following Bidaily Doses of Either 50 or 100 mg/kg Alisporivir (ALV) or NVP018 for 2 Weeks

p ≤ 0.05 compared with untreated mice. Values represent the average concentrations/numbers calculated in a group of 6 mice with standard deviation shown with error bars.